Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

COVID-19 infection may trigger alopecia areata in some patients.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.